These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23679328)

  • 1. Expression of MiR200a, miR93, metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma--relationship with prognosis.
    Wang L; Wang Q; Li HL; Han LY
    Asian Pac J Cancer Prev; 2013; 14(3):2113-8. PubMed ID: 23679328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer.
    Reis ST; Pontes-Junior J; Antunes AA; Dall'Oglio MF; Dip N; Passerotti CC; Rossini GA; Morais DR; Nesrallah AJ; Piantino C; Srougi M; Leite KR
    BMC Urol; 2012 May; 12():14. PubMed ID: 22642976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of RECK indicates a shorter survival for patients with invasive breast cancer.
    Zhang Y; Cheng S; Zhang G; Ma W; Liu Y; Zhao R; Zhang Q; Pang D
    Cancer Sci; 2012 Jun; 103(6):1084-9. PubMed ID: 22404079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer--results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial.
    Braicu EI; Gasimli K; Richter R; Nassir M; Kümmel S; Blohmer JU; Yalcinkaya I; Chekerov R; Ignat I; Ionescu A; Mentze M; Fotopoulou C; Pop C; Lichtenegger W; Sehouli J; ;
    Anticancer Res; 2014 Jan; 34(1):385-91. PubMed ID: 24403492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer.
    Pramanik KK; Singh AK; Alam M; Kashyap T; Mishra P; Panda AK; Dey RK; Rana A; Nagini S; Mishra R
    Tumour Biol; 2016 Nov; 37(11):15253-15264. PubMed ID: 27696293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase 9 in middle ear squamous cell carcinoma.
    Liu X; Wang W; Chen J; Chen C; Zhou J; Cao L
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(1):16-21. PubMed ID: 22178867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP-9/RECK Imbalance: A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatis.
    Discacciati MG; Gimenes F; Pennacchi PC; Faião-Flores F; Zeferino LC; Derchain SM; Teixeira JC; Costa MC; Zonta M; Termini L; Boccardo E; Longatto-Filho A; Consolaro ME; Villa LL; Maria-Engler SS
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1539-47. PubMed ID: 26261088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas.
    Ueda M; Terai Y; Yamashita Y; Kumagai K; Ueki K; Yamaguchi H; Akise D; Hung YC; Ueki M
    Int J Cancer; 2002 Mar; 98(3):335-43. PubMed ID: 11920583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between matrix metalloproteinase 2 and lung cancer progression.
    Guo CB; Wang S; Deng C; Zhang DL; Wang FL; Jin XQ
    Mol Diagn Ther; 2007; 11(3):183-92. PubMed ID: 17570740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
    Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
    Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
    Liu J; Ping W; Zu Y; Sun W
    Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma.
    Wang N; Zhang CQ; He JH; Duan XF; Wang YY; Ji X; Zang WQ; Li M; Ma YY; Wang T; Zhao GQ
    Dig Dis Sci; 2013 Jul; 58(7):1863-70. PubMed ID: 23504349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [miR-25 promotes cell proliferation by targeting RECK in human cervical carcinoma HeLa cells].
    Qiu G; Fang B; Xin G; Wei Q; Yuan X; Wu D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):40-3. PubMed ID: 25575057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [miR-181c promotes the migration and angiogenesis of human A549 cells via targeting inhibition of reversion-inducing cysteine-rich protein with Kazal motifs (RECK)].
    Liu C; Zhao F; Sun P; Han W; Hong M; Wu J; Zhang X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Dec; 38(12):1084-1090. PubMed ID: 36585230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
    Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
    Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer.
    Zhou X; Xu CJ; Wang JX; Dai T; Ye YP; Cui YM; Liao WT; Wu XL; Ou JP
    Int J Gynecol Cancer; 2015 Oct; 25(8):1353-63. PubMed ID: 26332389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.